Comparative QSAR studies using HQSAR, CoMFA, and CoMSIA methods on cyclic sulfone hydroxyethylamines as BACE1...

Area of Science:

• Medicinal Chemistry
• Computational Chemistry
• Neuroscience

Background:

• Alzheimer's disease (AD) is a progressive neurodegenerative disorder.
• Inhibition of beta-secretase (BACE1) is a primary therapeutic strategy for AD.
• Cyclic sulfone hydroxyethylamines show potential as BACE1 inhibitors.

Purpose of the Study:

• To perform 2D and 3D quantitative structure-activity relationship (QSAR) analyses on cyclic sulfone hydroxyethylamines as BACE1 inhibitors.
• To develop predictive models for designing novel and potent BACE1 inhibitors.
• To understand the key interactions between inhibitors and the BACE1 active site.

Main Methods:

• Hologram QSAR (HQSAR)
• Comparative Molecular Field Analysis (CoMFA)
• Comparative Molecular Similarity Indices Analysis (CoMSIA)
• Analysis of field distributions combined with BACE1 active site information

Main Results:

• Developed robust QSAR models with high predictive accuracy (HQSAR: q²=0.693, r²=0.981; CoMFA: q²=0.534, r²=0.913; CoMSIA: q²=0.512, r²=0.973).
• Identified key structural features contributing to BACE1 inhibitory activity.
• Visualized interactions between inhibitors and the BACE1 active site.

Conclusions:

• The developed QSAR models provide a valuable framework for the rational design of novel BACE1 inhibitors.
• This study facilitates the discovery of new therapeutic agents for Alzheimer's disease.
• Understanding structure-activity relationships is crucial for optimizing drug candidates.